From: Prediction of drugs having opposite effects on disease genes in a directed network
Disease (MeSH ID) | Drug (DrugBank ID) | Description in DrugBank | Supporting evidence from literature |
---|---|---|---|
OG (D009837) | Tetracycline (DB00759) | Bacterial infections | [27] |
TC (D013964) | Clomifene (DB00882) | Female infertility due to anovulation | n/a |
TC (D013964) | Fulvestrant (DB00947) | Metastatic breast cancer | [28] |
TC (D013964) | Ospemifene (DB04938) | Dyspareunia | n/a |
TC (D013964) | Cetuximab (DB00002) | Metastatic colorectal cancer | |
TC (D013964) | Gefitinib (DB00317) | Certain types of cancer | |
TC (D013964) | Erlotinib (DB00530) | Non-small cell lung cancer | |
TC (D013964) | Panitumumab (DB01269) | Antineoplastic agent | [36] |
AML (D015470) | Mecasermin (DB01277) | Primary IGF 1 deficiency | n/a |
TC (D013964) | Purvalanol (DB02733) | n/a | n/a |